Fund shareholders of CRESCENT BIOPHARMA INC
ISIN KYG2545C1042 · United States · LEI 549300TZ84FFU2J2J459
- Fund shareholders
- 24
- Of which ETFs
- 1 23 other funds
- Value held
- ≈ 33.1M $ 33.1M $ · 13.4K €
- Share of capital
- 5.3 % of 37.1M shares on Jul 27, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 698,846 | 12.8M $ | 0.00 % | 1.88 % | as of Mar 31, 2026 ↗ |
| Fidelity Growth Company Fund Fidelity Mt. Vernon Street Trust | 292,679 | 3.5M $ | 0.00 % | 0.79 % | as of Feb 28, 2026 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 251,090 | 5.6M $ | 0.30 % | 0.68 % | as of Apr 30, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 221,065 | 4.1M $ | 0.04 % | 0.60 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 113,421 | 1.4M $ | 0.03 % | 0.31 % | as of Feb 28, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 104,507 | 1.3M $ | 0.01 % | 0.28 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 81,936 | 1.5M $ | 0.00 % | 0.22 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Growth Company Fund Fidelity Mt. Vernon Street Trust | 69,195 | 836.6K $ | 0.00 % | 0.19 % | as of Feb 28, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 40,022 | 483.9K $ | 0.00 % | 0.11 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 17,631 | 323.9K $ | 0.05 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 12,699 | 153.5K $ | 0.00 % | 0.03 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 12,607 | 231.6K $ | 0.00 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 11,976 | 144.8K $ | 0.00 % | 0.03 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 10,017 | 121.1K $ | 0.00 % | 0.03 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Extended Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 8,300 | 152.5K $ | 0.02 % | 0.02 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 8,006 | 147.1K $ | 0.00 % | 0.02 % | as of Mar 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 5,959 | 109.5K $ | 0.05 % | 0.02 % | as of Mar 31, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 4,414 | 81.1K $ | 0.05 % | 0.01 % | as of Mar 31, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 3,989 | 48.2K $ | 0.00 % | 0.01 % | as of Feb 28, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 2,240 | 50.1K $ | 0.01 % | 0.01 % | as of Apr 30, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 276 | 5.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 200 | 3.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 114 | 2.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| CINVEST,FI CINVEST/ AZERO GLOBAL GESALCALA, S.A., S.G.I.I.C. | 13.4K € | 0.95 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| CINVEST,FI CINVEST/ AZERO GLOBAL GESALCALA, S.A., S.G.I.I.C. | 0.95 % | as of Dec 31, 2025 ↗ |
| Fidelity Advisor Biotechnology Fund Fidelity Advisor Series VII | 0.30 % | as of Apr 30, 2026 ↗ |
| EQ/T.Rowe Price Health Sciences Portfolio EQ Advisors Trust | 0.05 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Portfolio T. ROWE PRICE EQUITY SERIES, INC. | 0.05 % | as of Mar 31, 2026 ↗ |
| Health Sciences Trust John Hancock Variable Insurance Trust | 0.05 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Sciences Fund, Inc. T. ROWE PRICE HEALTH SCIENCES FUND, INC. | 0.04 % | as of Mar 31, 2026 ↗ |
| Select Biotechnology Portfolio Fidelity Select Portfolios | 0.03 % | as of Feb 28, 2026 ↗ |
| T. Rowe Price Extended Equity Market Index Fund T. ROWE PRICE INDEX TRUST, INC. | 0.02 % | as of Mar 31, 2026 ↗ |
| Victory Extended Market Index Fund Victory Portfolios III | 0.01 % | as of Apr 30, 2026 ↗ |
| Fidelity Growth Company K6 Fund Fidelity Mt. Vernon Street Trust | 0.01 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 23 | +6 | 1,971,189 | +75.6 % |
| 2026Q1 | 17 | +3 | 1,122,395 | +17.3 % |
| 2025Q4 | 14 | +12 | 956,820 | +3,502.9 % |
| 2025Q3 | 2 | 26,557 |
Cite this page
Titelia. "Fund shareholders of CRESCENT BIOPHARMA INC". https://titelia.com/en/stocks/crescent-biopharma-inc-KYG2545C1042